Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study (Q80238470)
Jump to navigation
Jump to search
scientific article published on 01 May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study |
scientific article published on 01 May 2007 |
Statements
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study (English)
Dinesh Khanna
Xiaohong Yan
Donald P Tashkin
Daniel E Furst
Robert Elashoff
Michael D Roth
Richard Silver
Marcy Bolster
James R Seibold
David J Riley
Vivien M Hsu
John Varga
Arthur Theodore
Fredrick Wigley
Barbara White
Virginia Steen
Charles Read
Maureen Mayes
Ed Parsley
Kamal Mubarak
M Kari Connolly
Jeffrey Golden
Mitchell Olman
Barri Fessler
Naomi Rothfield
Mark Metersky
Philip J Clements
Scleroderma Lung Study Group